Please login to the form below

Not currently logged in
Email:
Password:

laquinimod

This page shows the latest laquinimod news and features for those working in and with pharma, biotech and healthcare.

Teva cuts 25% of workforce, with Israel taking a heavy toll

Teva cuts 25% of workforce, with Israel taking a heavy toll

be successor laquinimod and an underperformance in its generic drug operations that have only been amplified by adding the Actavis business.

Latest news

More from news
Approximately 4 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics